- The race for an Ebola therapy beginsMale marathoners "hit the wall," mental health in 2026, and more Morning Rounds newsSTAT · 19d ago↗ source
- Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platformNovartis said Monday it will be spending $1.1 billion upfront to buy Myricx Bio, which has an antibody-drug conjugate payload platform that could offer an edge over current approaches. The Swiss…Endpoints · 19d ago↗ source
- Opinion: The smart way to regulate the peptide boom“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.STAT · 19d ago↗ source